Mindray Medical International

What Mindray Medical International does

Mindray Medical International is a China-founded, Shenzhen-headquartered medical device manufacturer established in 1991 and publicly listed on the Shenzhen Stock Exchange (ticker 300760). It develops, manufactures, and markets an integrated hospital equipment portfolio spanning patient monitoring (BeneVision N-Series, ePM, telemetry), ultrasound imaging (Resona, TE, Hepatus, DC, M-series, Imagyn), anesthesia workstations (A-Series), critical care ventilators (SV-Series), in-vitro diagnostics (BC hematology, BS/BA chemistry, CL chemiluminescence, CX coagulation analyzers), and adjacent surgical products such as the HyBase surgical tables, HyLED lights, and Hypixel endoscopic cameras. The proprietary technology base includes the Acoustic Intelligence Technology ultrasound platform, Zone Sonography Technology, integrated interoperability modules (BeneLink, eGateway), and an extensive US patent portfolio across all major product lines.

The company operates an enterprise field sales motion with direct sales teams, regional distribution partners, and dedicated regional organizations in North America (Mahwah, NJ) and Asia-Pacific (Singapore hub launched April 2026). Its revenue model combines upfront capital equipment sales with an installed-base-driven recurring layer of service contracts, reagent and consumable sales, and the Lifecycle Shield software/obsolescence program. 50% of revenue is international (up from 40% in 2021) and approximately 40% is recurring, with publicly stated targets to lift these above 60% and 50% respectively under a three-pillar growth strategy unveiled at the J.P. Morgan Healthcare Conference in January 2026.

Mindray sells into hospitals, diagnostic imaging centers, ambulatory surgery centers, intensive care units, clinical laboratories, veterinary practices, and emergency and primary care settings across more than 190 countries, with claimed penetration of 80 of the world's top 100 hospitals. Strategic acquisitions (HyTest in 2021 for EUR 545 million, DiaSys Diagnostic Systems in December 2023 for approximately USD 126 million, APT Medical in 2025 for cardiovascular intervention, and Lanyi (Hunan) Medical Devices in February 2026) have extended the company into reagent supply chains, IVD, and adjacent device segments. Recent corporate activity also includes a Singapore regional hub, partnership deals with EDB/NUS/A*STAR for medical AI and surgical robotics, an expanded Medtronic alliance for U.S. ambulatory surgery centers, and invitation-driven entries into Kazakhstan and South Africa.

Name

Mindray Medical International

Legal name

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Website

https://mindray.com

Company type

Public

Founded year

1991

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Mindray Medical International, founded in 1991 and headquartered in Shenzhen, China, is a publicly listed medical device manufacturer developing patient monitoring, ultrasound, anesthesia, ventilators, in-vitro diagnostics, and surgical equipment sold in 190+ countries to hospitals, ASCs, and clinical laboratories.

Ownership category

akta.pro rank

Product category

Medical Devices and Equipment

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)

akta.pro secondary industries

Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)

Keywords

• Patient monitoring systems
• Medical ultrasound imaging
• Anesthesia delivery workstations
• In-vitro diagnostic equipment
• Critical care ventilators

Headquarters

HQ city

Nanshan

HQ country

China

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Hardware Sales: Mindray generates primary revenue from selling medical equipment including patient monitors, ultrasound systems, anesthesia machines, ventilators, and in-vitro diagnostics instruments. The company derives 40% of revenue from recurring business and targets increasing this to 50%+
2. Service and Support Contracts: Extended warranties, service agreements, preventive maintenance, and lifecycle shield programs providing ongoing support revenue
3. Laboratory Diagnostics Reagents and Consumables: Hematology reagents, chemistry reagents, CLIA reagents, coagulation calibrators and controls for in-vitro diagnostic equipment

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Mindray develops, manufactures, and markets medical devices and equipment spanning patient monitoring systems, ultrasound imaging platforms, anesthesia workstations, critical care ventilators, and in-vitro diagnostic analyzers with associated reagents and consumables. The portfolio serves hospitals, diagnostic imaging centers, ambulatory surgery centers, and clinical laboratories across more than 190 countries, supported by service contracts, lifecycle maintenance programs, and IT interoperability solutions.

Product overview

Mindray Medical International is a comprehensive medical technology company offering an integrated portfolio of patient monitoring, ultrasound imaging, anesthesia, ventilators, in-vitro diagnostics, and surgical equipment solutions. The product ecosystem is organized around several core platforms: BeneVision patient monitoring systems (N-Series, ePM, telemetry, centralized monitoring with BeneLink interoperability), premium and point-of-care ultrasound systems (Resona, TE, Consona, DC, Imagyn, Hepatus series), anesthesia workstations (A-Series, WATO), critical care ventilators (SV Series), laboratory diagnostics (hematology analyzers BC series, chemistry analyzers BS/BA series, chemiluminescence immunoassay CL series, coagulation CX series), and surgical equipment (HyBase tables, HyLED lights, Hypixel endoscopic cameras). The company has expanded through acquisitions including HyTest (antibodies/antigens), DiaSys Diagnostic Systems (in-vitro diagnostics), and APT Medical (cardiovascular intervention), with products serving healthcare facilities across patient monitoring, imaging, respiratory care, laboratory testing, and surgical procedure needs.

Differentiator

Problem solved

Functional benefit

Brands

• Hytest: Antibodies and antigens for disease diagnostics, acquired by Mindray in 2021
• APT Medical
• Mindray Animal Medical

Products and services

• BeneVision N-Series Patient Monitors High-acuity patient monitoring platform (N22/N19/N17/N15/N12/N1) with advanced insights, seamless connectivity, and modular parameter design for critical care environments.
• ePM Patient Monitors Mid/low acuity patient monitors (ePM 10M/12M/15M) with smart workflow automation for continuous monitoring in general care settings.
• BeneVision TM80/TM70 Telemetry Monitors Wireless telemetry monitoring systems for continuous patient surveillance in intermediate care and telemetry departments.
• BeneVision Distributed Monitoring System (DMS) Centralized monitoring solution enabling clinicians to view and manage patient data from multiple monitors across the hospital network.
• VS 9/VS 8 Vital Signs Monitors Vital signs monitoring devices for spot checks and continuous measurement of blood pressure, SpO2, temperature, and other parameters.
• Resona A20 Ultrasound System Ultra premium ultrasound system built on Acoustic Intelligence Technology (AIT) platform, delivering advanced imaging, automation, and workflow tools for diagnostic excellence in general imaging applications.
• Resona Series Ultrasound Systems Premium and high-end ultrasound systems (Resona 7, Resona I9, Resona I8) for general imaging with advanced probe technology and imaging modes.
• Hepatus 6/Hepatus 5 Ultrasound Systems Specialized ultrasound systems for gastroenterology and hepatology diagnostics, integrating Visualized Transient Elastography (ViTE) with Liver Ultrasound Attenuation (LiSA).
• TE X Portable Ultrasound Point-of-care ultrasound system with rotatable 23.8-inch touchscreen, wireless transducer, and AI-powered smart tools including Auto EF Plus for cardiac function measurement.
• TE Air e5M Wireless Handheld Ultrasound Wireless handheld ultrasound device supporting 22 examination types with 120-minute battery life and three-year warranty for versatile whole-body scanning.
• A9/A8/A7 Anesthesia Workstations High-acuity anesthesia delivery systems featuring advanced ventilation, monitoring integration, and safety systems for complex surgical procedures.
• A5/A4 Anesthesia Systems Mid/low acuity anesthesia systems suitable for general surgical procedures with integrated monitoring capabilities.
• SV900/SV700 Ventilators Critical care ventilators delivering adaptable, flexible, and efficient respiratory care for patients of all ages with advanced ventilation modes.
• SV70 Non-Invasive Ventilator Non-invasive ventilation solution for respiratory care without intubation, designed for flexibility in critical care settings.
• BA-800M Chemistry Analyzer High-throughput chemistry analyzer for large test volume laboratory diagnostics.
• BC-5390 Hematology Analyzer 5-part differential hematology analyzer for comprehensive blood cell analysis in clinical diagnostics.
• CL-8000i/CL-6000i Chemiluminescence Immunoassay Analyzers High-throughput chemiluminescence immunoassay systems for clinical diagnostics including cardiac biomarkers, tumor markers, and infectious disease testing.
• CX-9000/CX-6000 Coagulation Analyzers Fully-automated coagulation analyzers for comprehensive hemostasis testing in clinical laboratories.
• BeneFusion Infusion System Comprehensive infusion management solutions including BeneFusion n Series, e Series, i Series, and u Series for precise drug delivery in hospital settings.
• BeneHeart Defibrillation/AED Series Defibrillation and AED solutions including BeneHeart L Series, C Series, D Series for emergency cardiac care and hospital resuscitation.
• BeneHeart ECG Systems Electrocardiograph systems including BeneHeart R700/R900, R300, R12, R3 for cardiac diagnostic monitoring.
• DigiEye Digital Radiography Systems Digital radiography solutions including DigiEye 680, 350, and 330 for general X-ray imaging in hospital radiology departments.
• MobiEye 700 Mobile Radiography System Mobile X-ray system for bedside imaging in ICU, emergency, and surgical settings.
• HyBase V6 Surgical Table Advanced surgical table with intelligent design and seamless operation for modern operating room environments.
• HyLED Surgical Light Series Surgical lighting solutions including HyLED X, C, Q, 8, 7, 600, and 200 series for modern operating room illumination.
• Hypixel Endoscopic Camera Systems Laparoscopic camera systems including UX7 Series (4K/NIR/3D), UX5 Series, UX3 Series for minimally invasive surgery visualization.
• HyTest Antibodies and Antigens Finnish-developed antibodies and antigens for disease diagnostics, acquired to strengthen in-vitro diagnostics portfolio, serving over 300 million patients globally.
• DiaSys Diagnostic Systems German in-vitro diagnostics company acquired in December 2023 to enhance global supply chain and expand in-vitro diagnostics footprint.
• APT Medical Cardiovascular Intervention Products Cardiovascular intervention and minimally invasive surgery products acquired to expand Mindray's presence in cardiovascular and minimally invasive surgical markets.
• Lifecycle Shield Agreement Software maintenance and obsolescence protection agreement providing scheduled patching, updates, and annual application upgrades for Mindray's installed equipment base.

Quantifiable outcome

• AI automation reducing exam times by 30-44% in diagnostic ultrasound workflows

Named customers1 record

Segments7 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability10 records

Feature8 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Economic Development Board (EDB), SingaporecoreStrategic or Co-development Partner · 20 April 2026Mindray Singapore signed strategic partnership agreement with Singapore's Economic Development Board as part of launching Mindray Singapore as a strategic regional hub for R&D, talent cultivation, and supply chain capabilities in medical technology.
• National University of Singapore (NUS)coreStrategic or Co-development Partner · 20 April 2026Mindray Singapore partnered with NUS to collaborate on medical AI, advanced medical imaging, in-vitro diagnostics, surgical robotics, and cardiovascular disease treatment as part of open, collaborative approach to advancing global health.
• Agency for Science, Technology and Research (A*STAR)coreStrategic or Co-development Partner · 20 April 2026Mindray Singapore signed strategic partnership with A*STAR to drive innovation in medical AI, advanced medical imaging, in-vitro diagnostics, surgical robotics, and cardiovascular disease treatment through joint research and development initiatives.
• Kazakhstan Medical InstitutionsminorStrategic or Co-development Partner · 17 April 2026Kazakh medical delegation led by the Medical Center of the President's Affairs Administration visited Mindray facilities and both sides agreed to expand cooperation in robotic surgery, AI-powered patient monitoring, digital operating rooms, automated pharmaceutical logistics, and joint education programs including internships.
• MedtroniccoreStrategic or Co-development Partner · 22 January 2026Medtronic and Mindray expanded their strategic partnership on patient monitoring to include ambulatory surgery centers (ASCs), integrating Medtronic's INVOS 7100 system and next-generation BIS brain monitoring into Mindray's platforms. The collaboration aims to deliver turnkey solutions for ASC providers, reducing costs, improving clinical outcomes, and simplifying purchasing and training processes as more procedures shift to outpatient settings in the U.S.
• APT MedicalcoreOthers · 15 January 2026Mindray announced strategic acquisition of APT Medical to expand into cardiovascular intervention and minimally invasive surgery markets as part of three-pillar growth strategy targeting Globalization, Recurring Business Expansion, and Intelli-Digitalization.
• DiaSys Diagnostic Systems GmbHcoreOthers · 1 December 2023Mindray acquired Germany's DiaSys Diagnostic Systems for approximately $126 million to strengthen its global position in in-vitro diagnostics, enhance global supply chain capabilities, and expand into medium- to large-scale customer segments.
• HyTestcoreOthers · 18 May 2021Mindray acquired HyTest, a Finnish developer of antibodies and antigens serving over 300 million patients globally, from Summa Equity for EUR545 million. HyTest maintains market leadership in several diagnostic segments and will strengthen Mindray's in-vitro diagnostics capabilities.

Scale indicators11 records

Recent moves9 records

Expansion highlights8 records

Direct peers

• GE HealthCare: GE HealthCare is a direct competitor to Mindray across patient monitoring, ultrasound imaging, and diagnostic equipment. Both companies target hospitals globally with comparable product portfolios in monitoring, ultrasound, and anesthesia delivery.
• Siemens Healthineers: Siemens Healthineers competes directly with Mindray in ultrasound imaging, diagnostic laboratory equipment, and patient monitoring. Both companies serve global hospital systems with premium and mid-tier imaging and diagnostic offerings.
• Canon Medical Systems: Canon Medical Systems competes with Mindray in ultrasound and diagnostic imaging, particularly in the Japanese and Asian markets. Both offer premium ultrasound systems and broader diagnostic imaging portfolios to hospital customers.
• Fujifilm Healthcare: Fujifilm Healthcare competes with Mindray in ultrasound, endoscopy, and medical imaging. Both companies offer comprehensive diagnostic imaging portfolios targeting hospitals and specialty centers globally.
• Philips (Royal Philips): Philips is a direct competitor to Mindray in patient monitoring, ultrasound, and connected care solutions. Both target hospital systems globally with comprehensive monitoring and imaging portfolios, including interoperability platforms analogous to Mindray's BeneVision ecosystem.

Broad incumbents

• Medtronic: Medtronic is both a strategic partner to Mindray (for ASC patient monitoring integration) and a broader medtech incumbent competing in adjacent areas such as patient monitoring, surgical, and cardiovascular intervention where Mindray's APT Medical operates.
• Stryker: Stryker is a broad medical technology incumbent competing with Mindray in surgical equipment, operating room integration, and selected imaging. Both serve hospital surgical departments with capital equipment and consumables portfolios.

Emerging players

• Edwards Lifesciences: Edwards Lifesciences is relevant as a comparator in cardiovascular intervention and critical care patient monitoring, an area where Mindray is expanding via the APT Medical acquisition. Both serve ICU and cardiovascular care settings globally.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/mindraysupport
• Facebookfacebook.com/107882162572745
• LinkedInlinkedin.com/company/shenzhen-mindray-bio-medical-electronics-co--ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mindray Medical International